TrialJNCI cancer spectrum2026

Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.

Azka Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.